TECTA
TAKEDA CANADA INC
View this drug's full profile page →
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is there a shortage of TECTA in Canada?
A shortage of TECTA 40MG is expected: the manufacturer reported it to Health Canada as an anticipated shortage (last updated October 15, 2026), but it has not started yet.
Why is TECTA not available?
The reason the manufacturer reported: Demand increase for the drug.
When will TECTA be available again?
The manufacturer's estimated resolution date is January 11, 2027. This is an estimate and can change; follow this page to get an email when the status changes.
Is Tecta Still on Backorder in Canada? 2026 Shortage Status
Is Tecta (pantoprazole magnesium 40mg, DIN 02267233) available in Canada again? Its latest backorder was marked resolved on October 6, 2026 — live status, why it went short, and why a generic pantoprazole isn't always a simple swap.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
PANTOLOC
TAKEDA CANADA INC
Other Products
AURO-PANTOPRAZOLE
AURO PHARMA INC
PMS-PANTOPRAZOLE
PHARMASCIENCE INC
PANTOPRAZOLE FOR INJECTION
FRESENIUS KABI CANADA LTD
JAMP-PANTOPRAZOLE
JAMP PHARMA CORPORATION
SPC-PANTOPRAZOLE
SUN PHARMA CANADA INC
What this means
Does this mean my pharmacy is already out of stock?
No — this shortage hasn't started yet. It's an early warning that supply may become tight, based on information from the manufacturer.
What should I do?
No action is needed yet. It's worth asking your pharmacist at your next refill whether they expect any disruption for this product.
Estimated Resolution
2027-01-11
~3 months remaining (estimate)
This is the manufacturer's estimated date, not a guarantee — actual resolution may come earlier or later.
DIN
02267233
Strength
40MG
Dosage Form
TABLET (ENTERIC-COATED)
Route
ORAL
Active Ingredient
PANTOPRAZOLE
Tier
Unrated
Last Updated
2026-10-15
Reason for Shortage
Demand increase for the drug.
Past Reports for This Drug
TECTA has 3 shortage/discontinuation reports on file — this is one of them.
Other Products from TAKEDA CANADA INC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
45MG · DIN 02242574
30MG · DIN 02242573
15MG · DIN 02242572
30MG · DIN 02248813
20MG · DIN 02248811
5MG · DIN 02248808
15MG · DIN 02248810
10MG · DIN 02248809
25MG · DIN 02248812
3000UNIT · DIN 02498626
250UNIT · DIN 02498537
500UNIT · DIN 02498545